NCT02437656 2026-03-16
METCAP
Centre Oscar Lambret
Phase 2 Completed
Clinical Trials
43 trialsNCT02186847 2025-10-09
Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer
NRG Oncology
Phase 2 Completed
NCT01750567 2025-09-09
A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT04300790 2025-07-29
METALLICA
MedSIR
Phase 2 Completed
NCT02488564 2025-02-03
met-HEReMYTA
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2 Completed
NCT04275713 2025-01-20
METOXY-LACC
Oslo University Hospital
Phase 2 Completed
NCT02035787 2024-12-18
Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT03800602 2024-09-05
Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer
Emory University
Phase 2 Completed
NCT02431676 2024-08-28
SPIRIT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT02028221 2023-06-27
Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk
University of Arizona
Phase 2 Completed
NCT05351021 2023-03-09
Efficacy of Metformin as Preventive Treatment in Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients
Mansoura University
Phase 2 Completed
NCT03200015 2022-11-07
Rituximab, Cyclophosphamide, Vincristine and Prednisone (R-CHOP) Plus Metformin in Diffuse Large-B-cell Lymphoma
Hospital Universitario Dr. Jose E. Gonzalez
Phase 2 Completed
NCT00930579 2022-10-20
Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation
Columbia University
Phase 2 Completed
NCT02176161 2022-10-18
Metformin Prostate Cancer Adjuvant Trial
NYU Langone Health
Phase 2 Completed
NCT04170465 2022-09-10
METNEO
Damanhour University
Phase 2 Completed
NCT02614859 2022-03-29
BIMET-1
Fox Chase Cancer Center
Phase 2 Completed
NCT04143282 2021-12-07
Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment
Beni-Suef University
Phase 2 Completed
NCT05053841 2021-09-23
Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women
Tanta University
Phase 2 Completed
NCT01725490 2021-09-20
The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled Study
Yonsei University
Phase 2 Completed
NCT04867252 2021-09-13
Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome
Khyber Medical University Peshawar
Phase 2 Completed
NCT01666730 2021-08-10
Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer
Case Comprehensive Cancer Center
Phase 2 Completed
NCT01210911 2021-04-21
GEM
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2 Completed
NCT02394652 2021-04-21
The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial
University Health Network, Toronto
Phase 2 Completed
NCT01310231 2021-04-14
A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer
Ozmosis Research Inc.
Phase 2 Completed
NCT03086733 2020-08-19
Metcore
University Health Network, Toronto
Phase 2 Completed
NCT03674385 2020-07-10
Efficacy of Vit E in PCOS Resistant to Clomiphene Citrate
Ain Shams University
Phase 2 Completed
NCT01243385 2019-08-13
Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer
Swiss Cancer Institute
Phase 2 Completed
NCT01312467 2019-03-05
Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI
National Cancer Institute (NCI)
Phase 2 Completed
NCT01677897 2019-03-05
MetAb-Pro
Kantonsspital Graubünden
Phase 2 Completed
NCT02005419 2019-02-05
Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection
Fudan University
Phase 2 Completed
NCT03259919 2018-10-18
pilPregMet
Norwegian University of Science and Technology
Phase 2 Completed
NCT01864681 2018-06-20
CGMT
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2 Completed
NCT01796028 2018-06-06
TAXOMET
Centre Antoine Lacassagne
Phase 2 Completed
NCT01579812 2018-05-25
Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT01620593 2018-05-23
Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer
The University of Texas Health Science Center at San Antonio
Phase 2 Completed
NCT00151411 2018-03-21
Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)
Milton S. Hershey Medical Center
Phase 2 Completed
NCT01433913 2018-01-10
Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
National Cancer Institute (NCI)
Phase 2 Completed
NCT01885013 2016-01-01
MYME
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2 Completed
NCT00909506 2015-07-29
Efficacy and Safety of Adjuvant Metformin for Operable Breast Cancer Patients
Seoul National University Hospital
Phase 2 Completed
NCT01941953 2015-04-08
Metformin and 5-fluorouracil for Refractory Colorectal Cancer.
Instituto do Cancer do Estado de São Paulo
Phase 2 Completed
NCT01447927 2014-07-21
Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 2 Completed
NCT01266486 2014-07-02
Effect of Metformin on Breast Cancer Metabolism
Oxford University Hospitals NHS Trust
Phase 2 Completed
NCT00344851 2007-07-11
Exenatide and Metformin Therapy in Overweight Women With PCOS
Metabolic Center of Louisiana Research Foundation
Phase 2 Completed